+987.9%
MRNA vs NVT
+3.0%
+984.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NVT | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -12.7% | +25.8% | +12.0% |
| 7D | +20.6% | -19.5% | +40.1% | +19.1% |
| 30D | +27.1% | -32.4% | +59.5% | +22.3% |
| 3M | +353.4% | -30.3% | +383.7% | +338.8% |
| 6M | +446.3% | -30.4% | +476.7% | +416.6% |
| YTD | +776.2% | +11.3% | +764.8% | +551.2% |
| 1Y | +987.9% | +3.6% | +984.3% | +730.0% |
| All | +987.9% | +3.0% | +984.9% | +730.0% |
Cumulative growth
Daily Returns
Daily percentage return beside NVT.
Daily Out/Under-Performance
Portfolio return minus NVT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NVT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NVT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling